← Open Payments lookup

SKYE MURRAY: Open Payments

NPI 1457641169 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$974 in 66 payments from 15 companies in 2025. Trend: 2023 $548 · 2024 $664 · 2025 $974

Food & beverage: $974
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation22$196
Amgen Inc.12$169
AstraZeneca Pharmaceuticals LP5$92
Novo Nordisk Inc4$89
Merck Sharp & Dohme LLC4$71
Boston Scientific Corporation2$63
BridgeBio Pharma, Inc.3$56
PFIZER INC.2$45
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)3$41
E.R. Squibb & Sons, L.L.C.2$39

Products named: LEQVIO, REPATHA, VERQUVO, WATCHMAN Access System, Attruby, FARXIGA, Ozempic, Rybelsus.

Industry payments across NE — which companies pay providers there.